Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
A. Roessler, A. Netzl, L. Knabl…·J. Kimpel
This study compares neutralizing antibody titers in human and hamster sera against SARS-CoV-2 variants using a live-virus neutralization assay, finding hamster sera show higher reactivity.
F. Costacurta, A. Dodaro, D. Bante…·E. Heilmann
This study identifies and characterizes SARS-CoV-2 Mpro mutations conferring resistance to nirmatrelvir using a VSV-based system and biochemical assays.
S. A. Moghadasi, E. Heilmann, A. Khalil…·R. Harris
The paper identifies SARS-CoV-2 variants resistant to protease inhibitors nirmatrelvir and ensitrelvir, showing pre-existing resistance and potential for spread.
E. Heilmann, F. Costacurta, A. Volland, D. von Laer
The paper identifies SARS-CoV-2 3CLpro mutations that confer resistance to Paxlovid using a VSV-based system and finds these mutations already exist in viral sequences.
A. Popa, J.-W. Genger, M. Nicholson…·A. Bergthaler
This study analyzes SARS-CoV-2 superspreading events in Austria using genomic and epidemiological data to understand viral transmission and mutation dynamics.